NEW YORK, N.Y. – November 1, 2022 – Castor, a leading provider of decentralized and hybrid clinical trial technology solutions, today announced a new offering to simplify post-marketing clinical trials. By extending global reach, integrating real-world data (RWD), and automating trial processes, Castor’s latest offering can reduce trial costs by 30% and deployment timelines to only 4 weeks on average.
“Real-world evidence has the potential to transform evidence based medicine, by generating a body of evidence that provides a much more accurate view on what cure is best for each individual patient, through including a more diverse range of patients and in everyday settings,” said CEO and co-founder Derk Arts, M.D, Ph.D. “Our latest offering simplifies the creation of RWE into clinical trials and supports life science companies in their pursuit of drug discovery and development goals.”
Castor RWE addresses common PMCT challenges by easily integrating real-world data sources such as patient-reported outcomes and wearables to increase patient access and retention as well as data quality and compliance. The offering, Castor Real-World Evidence (RWE), provides integrated technology and services to accelerate the collection of RWD for post-marketing clinical trials (PMCT), enabling life science companies to meet regulatory and payer requirements efficiently.
The offering includes pre-configured modules for patient recruitment, eligibility screening, enrollment, data capture, and participant engagement. This comprehensive approach helps sponsors uncover valuable insights into drug performance in real-world settings, while expanding access to global trial populations.
“We are committed to supporting life science companies in all aspects of their clinical trials, from early drug discovery to post-marketing studies,” said Castor CPTO Andy Sadler.“Castor RWE is a natural extension of our platform, and we are excited to provide this solution to our clients.”
To learn more about Castor RWE visit https://www.castoredc.com/real-world-evidence/.
Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest-rated eClinical platform, Castor’s modular platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment and real-world data capture. Castor is bringing human-centered design to the clinical trial process, from recruitment to monitoring, and improving the quality, security, and reusability of data for researchers worldwide. For more information, visit www.castoredc.com. Follow Castor on LinkedIn or Twitter.
Dana Perotti, [email protected]
Kimberly Ha, [email protected]